Login

Dr. Sundar Kamath, Senior VP & CTO of Sanmina Corp, San Jose, CA. 00:10:00

Share On Facebook Share On Twitter

Jure Sola is Chairman and Chief Executive Officer of Sanmina Corp

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Christian Jansson, CEO of Godsinlösen Nordics, Discusses Upcoming First North Listing | Christian Jansson, CEO , Godsinlösen Nordics AB.
00:10:00
John Connaughton on Pandemic Impact and Strategic Investing | John Connaughton, Co-Managing Partner ,  Bain Capital .
00:10:00
AI Investment Opportunities: Insights from Columbia Threadneedle Investments
00:00:00
Emerging class of drugs for the treatment of chronic and age-related diseases - JOSEPH J. SARRET, M.D., J.D. Chief Executive Officer and Director, CohBar Inc
00:10:00
Unlocking Value in Mexico: Kootenai Silver's Expansion Plans and Exploration Focus
00:10:00
Expectations for Canada's Throne Speech: Health, Jobs, and Fiscal Prudence Amidst Economic Challenges| Nancy Southern , CEO, Atco Ltd.
00:10:00
Rising Electricity and Gas Prices Raise Concerns for Residents and Businesses in Lithuania | Darius Maikštenas, CEO, Ignitis Grupe AB.
00:10:00
Dr. Clarence Moniba's Journey and Liberia's Historical Context|Clarence K. Moniba
00:10:00
Aim to deliver strong returns and shared success to those we serve and the world at large|Scott Nuttall,CO-CHIEF EXECUTIVE OFFICER,KKR & Co LP
00:10:00
Demographic Decline and Cultural Transformation: Insights from Mark Steyn|Mark Steyn
00:10:00
Buddy CRM and VenuIQ's long association with Kellton | David McLauchlan, CEO, Buddy Platform Ltd BUD:ASX
00:10:00
India's Economic Evolution: From FX Crisis to Surplus, Digital Revolution, and Infrastructure Growth | Nilesh Shah, CEO , Kotak Mutual Fund.

© 2017 - Neuhu+